This website uses cookies to collect usage information in order to offer a better browsing experience. By browsing this site or by clicking on the "ACCEPT COOKIES" button you accept our Cookie Policy.

Benzinga is a fast-growing financial media outlet that empowers investors with market-moving content. The site also manages Benzinga Pro, a streaming platform with real-time headlines, data and actionable alerts. Sign up for a free trial and profit with faster news now.

Benzinga

May 27, 2021

GameStop, AMC Short Seller Losses For 2021 Widen To $8B

Investors betting against GameStop Corp. and AMC Entertainment Holdings Inc. have lost more than $8 billion in the year-to-date period following the latest rally in the “meme” stocks, according to a report by Reuters that cited data from financial analytics firm S3 Partners.

Read More
Benzinga

May 14, 2021

Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day

Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding after the company posted its first operating loss as a listed company, as a record regulatory fine it was slapped with last month weighed on its earnings.

Read More
Benzinga

April 26, 2021

Is SafeMoon Overtaking Dogecoin?

Both Dogecoin (DOGE) and SafeMoon (SAFEMOON) have hit their all-time highs in the recent past but is the latter outpacing the Shiba Inu-themed cryptocurrency in terms of gains?

Read More
Benzinga

April 22, 2021

Stock Wars: HubSpot Vs. Salesforce

In this week’s installment, we present a duel between two of the leading U.S. business software companies: HubSpot Inc (NYSE:HUBS) and salesforce.com, inc. (NYSE:CRM).

Read More
Benzinga

April 12, 2021

A Peek Into The Markets: April 12, 2021

U.S. stock futures traded lower in early pre-market trade after the Dow Jones added around 300 points in the previous session. Investors are awaiting earnings results from Aphria Inc.

Read More
Benzinga

April 9, 2021

The Daily Biotech Pulse: April 9, 2021

Here’s a roundup of top developments in the biotech space over the last 24 hours: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs

Read More
trading top